Literature DB >> 19066996

Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.

Elena Cichero1, Sara Cesarini, Andrea Spallarossa, Luisa Mosti, Paola Fossa.   

Abstract

Symmetric formimidoester disulfides (DSs) have recently been identified as a new class of potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Given that three geometric isomers for DSs are possible, a computational strategy based on molecular docking studies, followed by comparative molecular fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was used in order to identify the most probable DS isomer interacting with RT, to elucidate the atomic details of the RT/DS interaction, and to identify key features impacting DS antiretroviral activity. The CoMFA model was found to be the more predictive, with values of r(2)ncv, r(2)cv, SEE = 0.264, F = 80, and r(2)pred=0.73.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066996     DOI: 10.1007/s00894-008-0402-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

Review 1.  New developments in anti-HIV chemotherapy.

Authors:  E De Clercq
Journal:  Farmaco       Date:  2001 Jan-Feb

Review 2.  Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

Authors:  Giuseppe Campiani; Anna Ramunno; Giovanni Maga; Vito Nacci; Caterina Fattorusso; Bruno Catalanotti; Elena Morelli; Ettore Novellino
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 3.  Emerging anti-HIV drugs.

Authors:  Erik De Clercq
Journal:  Expert Opin Emerg Drugs       Date:  2005-05       Impact factor: 4.191

4.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

5.  Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives.

Authors:  Angelo Ranise; Andrea Spallarossa; Silvia Schenone; Olga Bruno; Francesco Bondavalli; Laura Vargiu; Tiziana Marceddu; Massimo Mura; Paolo La Colla; Alessandra Pani
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

Review 6.  New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.

Authors:  Rudi Pauwels
Journal:  Curr Opin Pharmacol       Date:  2004-10       Impact factor: 5.547

Review 7.  Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

Authors:  J Balzarini
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

8.  Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.

Authors:  Andrea Spallarossa; Sara Cesarini; Angelo Ranise; Marco Ponassi; Torsten Unge; Martino Bolognesi
Journal:  Biochem Biophys Res Commun       Date:  2007-11-21       Impact factor: 3.575

9.  Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate.

Authors:  Sara Cesarini; Andrea Spallarossa; Angelo Ranise; Olga Bruno; Paolo La Colla; Barbara Secci; Gabriella Collu; Roberta Loddo
Journal:  Bioorg Med Chem       Date:  2007-12-25       Impact factor: 3.641

10.  Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates.

Authors:  Sara Cesarini; Andrea Spallarossa; Angelo Ranise; Paola Fossa; Paolo La Colla; Giuseppina Sanna; Gabriella Collu; Roberta Loddo
Journal:  Bioorg Med Chem       Date:  2007-12-25       Impact factor: 3.641

View more
  3 in total

1.  Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2010-09-28       Impact factor: 5.923

2.  Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2011-03-01       Impact factor: 5.923

3.  Alkylated benzimidazoles: Design, synthesis, docking, DFT analysis, ADMET property, molecular dynamics and activity against HIV and YFV.

Authors:  Ritika Srivastava; Sunil K Gupta; Farha Naaz; Parth Sarthi Sen Gupta; Madhu Yadav; Vishal Kumar Singh; Anuradha Singh; Malay Kumar Rana; Satish Kumar Gupta; Dominique Schols; Ramendra K Singh
Journal:  Comput Biol Chem       Date:  2020-10-06       Impact factor: 2.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.